Withdrawn study sought to understand sinus problems in young cancer survivors
NCT ID NCT05454163
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aimed to find out how often chronic sinusitis occurs in children treated for head and neck cancer, and how it affects their quality of life. Researchers planned to compare these children to those treated for cancer elsewhere in the body using a questionnaire called SNOT 22. However, the study was withdrawn before any participants were enrolled.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could show whether children treated for head and neck cancer need special follow-up for chronic sinusitis.
- What could go wrong
- The study was withdrawn before enrolling anyone, so no results are available. It is an observational study, not a treatment trial.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Started
-
Oct 2022
- Finished
-
Oct 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population (called exposed) concerns all patients under 18 years of age managed for a head neck mesenchymal cancer between January 1, 2018 and December 31, 2024 in the pediatric surgery department of the Lille University Hospital. The control population (called non-exposed) included children treated during the same period for a non-head neck mesenchymal malignant cancer
- Ages
-
Up to 18 years
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Study population: all patients under 18 years of age managed for a head neck mesenchymal cancer between January 1, 2018 and December 31, 2024 * Control population: all patient under 1 years of age managed for non -head neck mesenchymal cancer between January 1, 2018 and December 31, 2024 Exclusion Criteria: * Patients with hematological tumors; * Patients with mucociliary pathologies or proven allergic rhinitis before the diagnosis of cancer * Patients who have required surgical treatment that has removed more than half of the sinus cavities * Tumor recurrence at the time of inclusion * Sinus surgery between the last radiological check-up and inclusion * Administrative reasons: inability to receive informed information.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic sinusitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Sinus surgery without opioids: can dexmedetomidine do the job?
- Can freezing ovarian tissue protect fertility in children facing cancer treatment?
- Tumor profiling may unlock targeted drug options for pediatric cancers
- Can a new pill tame childhood cancers that Won't quit?
- A bike ride could reveal hidden heart risks in young cancer survivors
- Can a new combo drug tame childhood leukemia that Won't quit?